ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,235Medicare Part D Prescriptions Filled, Including Refills

Rank: 94 out of 2456

$953K Total Retail Price of All Prescriptions

Rank: 39 out of 2456

584 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
25% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 584 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

7% of this provider’s 584 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

2% of this provider’s 11,659 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$72 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
SIMVASTATIN 686 617 1 2
LISINOPRIL 508 441 2 1
LEVOTHYROXINE SODIUM 473 356 3 4
OMEPRAZOLE 380 320 4 3
PRAVASTATIN SODIUM 342 339 5 15
ATENOLOL 297 292 6 6
AMLODIPINE BESYLATE 292 276 7 5
ATORVASTATIN CALCIUM 246 239 8 12
LOSARTAN POTASSIUM 242 211 9 18
HYDROCHLOROTHIAZIDE 229 219 10 7
WARFARIN SODIUM 217 217 11 9
FUROSEMIDE 208 197 12 8
METFORMIN HCL 203 155 13 11
METOPROLOL TARTRATE 196 190 14 10
ALLOPURINOL 191 179 15 27
ADVAIR DISKUS 156 129 16 36
METOPROLOL SUCCINATE 148 133 17 13
ZOLPIDEM TARTRATE 148 136 17 28
GABAPENTIN 143 129 19 16
METFORMIN HCL ER 137 115 20 59
TRIAMTERENE-HCTZ 137 135 20 53
CITALOPRAM HBR 133 119 22 14
DONEPEZIL HCL 121 121 23 23
TRAMADOL HCL 110 84 24 24
FENOFIBRATE 107 78 25 68
RANITIDINE HCL 107 80 25 31
LEVOXYL 104 104 27 97
TAMSULOSIN HCL 100 90 28 32
NAMENDA 98 98 29 42
FLUOXETINE HCL 96 88 30 45
FLUTICASONE PROPIONATE 89 55 31 30
LANTUS 87 85 32 44
FINASTERIDE 86 86 33 66
TRAZODONE HCL 85 73 34 17
JANUVIA 85 85 34 81
PANTOPRAZOLE SODIUM 83 61 36 37
TERAZOSIN HCL 77 76 37 76
LISINOPRIL-HYDROCHLOROTHIAZIDE 76 65 38 41
SERTRALINE HCL 75 75 39 21
LOSARTAN-HYDROCHLOROTHIAZIDE 75 75 39 117
INSULIN SYRINGE 72 66 41 72
VERAPAMIL ER 71 68 42 91
POTASSIUM CHLORIDE 71 58 42 33
DILTIAZEM 24HR ER 69 68 44 78
NYSTATIN 67 59 45 99
HYDROCODONE-ACETAMINOPHEN 65 40 S3 46 20
CRESTOR 65 42 46 25
TORSEMIDE 64 63 48 146
SINGULAIR 63 36 49 149
BUPROPION HCL SR 63 58 49 119
OXYBUTYNIN CHLORIDE ER 60 60 51 94
CLOPIDOGREL 60 60 51 55
VENLAFAXINE HCL ER 58 55 53 92
LORAZEPAM 58 58 53 67
NOVOLOG 57 48 55 100
CARVEDILOL 57 57 55 54
EVISTA 57 55 55 143
PEN NEEDLE 57 39 55 150
GLIMEPIRIDE 56 56 59 74
GLYBURIDE 56 49 R 59 40
ESCITALOPRAM OXALATE 55 55 61 116
AMITRIPTYLINE HCL 53 41 R 62 83
PLAVIX 51 51 63 79
PROAIR HFA 50 34 64 22
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 26, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.